Trinity Biotech (TRIB) Debt Ratio (2009 - 2025)

Trinity Biotech has disclosed Debt Ratio across 15 years of filings, most recently posting 0.84 for Q2 2025.

• Debt Ratio for Q2 2025 came in at 0.84, up 17.78% year-over-year; the trailing twelve-month figure through Jun 2025 was 0.84 (up 17.78% YoY), and the FY2024 annual result was 0.72, up 4.86% from the prior year.
• Debt Ratio came in at 0.84 for Q2 2025 at Trinity Biotech, up from 0.72 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.84 in Q2 2025 to a low of 0.0 in Q4 2021.
• The 5-year median for Debt Ratio is 0.66 (2023), against an average of 0.59.
• Across the five-year window, Debt Ratio jumped 190908.26% in 2022 and dropped 24.24% in 2023, its largest moves.
• Trinity Biotech's Debt Ratio stood at 0.0 in 2021, then surged by 190908.26% to 0.5 in 2022, then jumped by 37.28% to 0.68 in 2023, then climbed by 4.86% to 0.72 in 2024, then advanced by 17.1% to 0.84 in 2025.
• The last three Debt Ratio figures came in at 0.84 (Q2 2025), 0.72 (Q4 2024), and 0.69 (Q3 2024), per Business Quant data.